We have evaluated the effects of intravitreal dobesilate, a synthetic fibroblast growth factor inhibitor, in patients with dry age-related macular degeneration, an inflammatory-related retinal disease without available treatment up to date. 36 eyes from 36 patients with dry age-related macular degeneration were treated with a single intravitreal dobesilate injection. The end points were the improvement from baseline visual acuity and normalization of retinal histology at one month . Intravitreal dobesilate injection resulted in a significant improvement in functional and anatomical outcomes at one month after injection. Our results suggest that intravitreal dobesilate may increase the chance of visual acuity gain in dry age-related macular degeneration, even in cases with initial low vision. This study supports the findings of previously published case reports, regarding the short-term improvement in visual acuity by intravitreal dobesilate injection in different degenerative retinal diseases.
Ambati, J., Ambati, B.K., Yoo, S.H., Ianchulev, S. and Adamis, A.P. (2003) Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Survey of Ophthalmology, 48, 257-293. http://dx.doi.org/10.1016/S0039-6257(03)00030-4
van Leeuwen, R., Klaver, C.C., Vingerling, J.R., Hofman, A. and de Jong, P.T. (2003) Epidemiology of age-related maculopathy: A review. European Journal of Epidemiology, 18, 845-854. http://dx.doi.org/10.1023/A:1025643303914
Klein, R., Klein, B.E., Knudtson, M.D., Meuer, S.M., Swift, M. and Gangnon, R.E. (2007) Fifteen-year cumulative incidence of age-related macular degeneration: The beaver dam eye study. Ophthalmology, 114, 253-262. http://dx.doi.org/10.1016/j.ophtha.2006.10.040
Patel, M. and Chan, C.C. (2008) Immunopathological aspects of age-related macular degeneration. Seminars in Immunopathology, 30, 97-110. http://dx.doi.org/10.1159/000099293
Buschini, E., Piras, A., Nuzzi, R. and Vercelli, A. (2011) Age related macular degeneration and drusen: Neuroinflammation in the retina. Progress in Neurobiology, 95, 14-25. http://dx.doi.org/10.1016/j.pneurobio.2011.05.011
Telander, D.G. (2011) Inflammation and age-related macular degeneration (AMD). Seminars in Ophthalmology, 26, 192-197. http://dx.doi.org/10.1016/j.pneurobio.2011.05.011
Byrd, V.M., Ballard, D.W., Miller, G.G. and Thomas, J.W. (1999) Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells. Journal of Immunology, 162, 5853-5859.
Meij, J.T., Sheikh, F., Jiménez, S.K., Nickerson, P.W., Kardami, E. and Cattini, P.A. (2002) Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. American Journal of Physiology— Heart and Circulatory Physiology, 282, H547-H555.
Rossini, M., Cheunsuchon, B., Donnert, E., Ma, L.J., Thomas, J.W., Neilson, E.G. and Fogo, A.B. (2005) Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney International, 68, 2621-2628. http://dx.doi.org/10.1111/j.1523-1755.2005.00734.x
Zittermann, S.I. and Issekutz, A.C. (2006) Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. American Journal of Pathology, 168, 835-846. http://dx.doi.org/10.2353/ajpath.2006.050479
Andrés, G., Leali, D., Mitola, S., Coltrini, D., Camozzi, M., Corsini, M., Belleri, M., Hirsch, E., Schwendener, R.A., Christofori, G., Alcami, A. and Presta, M. (2009) A pro-inflammatory signatura mediates FGF2-induced angiogenesis. Journal of Cellular and Molecular Medicine, 13, 2083-2108. http://dx.doi.org/10.1111/j.1582-4934.2008.00415.x
Strowig, T., Henao-Mejía, J., Elinav, E. and Flawell, R. (2012) Inflammosomes in health and disease. Nature, 481, 278-296. http://dx.doi.org/10.1038/nature10759
Stewart, M.W. (2012) The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clinic Proceedings, 87, 77-88. http://dx.doi.org/10.1016/j.mayocp.2011.10.001
Lee, M., Kang, Y., Suk, K., Schwab, C., Yu, S. and McGeer, P.L. (2011) Acidic fibroblast growth factor (FGF) potentiates glial-mediated neurotoxicity by activating FGFR2 IIIb protein. Journal of Biological Chemistry, 286, 41230-41245. http://dx.doi.org/10.1074/jbc.M111.270470
Verma, L., Sinha, R., Venkatesh, P. and Tewari, H.K. (2004) Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: A pilot, randomized controlled trial [ISRC-TN84128484]. BMC Ophthalmology, 4, 15. http://dx.doi.org/10.1186/1471-2415-4-15
Sarks, J.P., Sarks, S.H. and Killingsworth, M.C. (1988) Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond), 2, 552-577. http://dx.doi.org/10.1038/eye.1988.106
Fernández, I.S., Cuevas, P., Angulo, J., López-Navajas, P., Canales-Mayordomo, A., Lozano, R.M., Valverde, S., Jiménez-Barbero, J., Romero, A. and Giménez-Gallego, G. (2010) Gentisic acid, a compound associated with plant defence and a metabolite of aspirin, heads a new class of in vivo FGF inhibitor. The Journal of Biological Chemistry, 285, 1714-1729. http://dx.doi.org/10.1074/jbc.M109.064618
Cuevas, P., Outeirino, L.A., Azanza, C. and Giménez-Gallego, G. (2012) Intravitreal dobesilate in the treatment of choroidal neovascularization associated with age-related macular degeneration. Report of two cases. British Medical Journal (BMJ) Case Reports.
Cuevas, P., Outeirino, L.A., Azanza, C., Angulo, J. and Giménez-Gallego, G. (2012) Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy. European Journal of Medical Research, 17, 22. http://dx.doi.org/10.1186/2047-783X-17-22
Cuevas, P., Outeirino, L.A., Angulo, J. and Giménez-Gallego, G. (2012) Chronic cystoid macular oedema treated with intravitreal dobesilate. British Medical Journal (BMJ) Case Reports.
Cuevas, P., Outeirino, L.A., Angulo, J. and Giménez-Gallego, G. (2012) Treatment of dry age-related macular degeneration with dobesilate. British Medical Journal (BMJ) Case Reports.
Cuevas, P., Outeirino, L.A., Angulo, J. and Giménez-Gallego, G. (2012) Treatment of Stargardt disease with dobesilate. British Medical Journal (BMJ) Case Reports.
Thomas, K.A. and Giménez-Gallego, G. (1986) Fibroblast growth factors: Broad spectrum mitogens with potent angiogenic activity. Trends in Biochemical Sciences, 11, 81-84. http://dx.doi.org/10.1016/0968-0004(86)90271-9
Cuevas, P., Carceller, F., Ortega, S., Zazo, M., Nieto, I. and Giménez-Gallego, G. (1991) Hypotensive activity of fibroblast growth factor. Science, 254, 1208-1210. http://dx.doi.org/10.1126/science.1957172
Galan, J.M., Cuevas, B., Dujovny, N., Giménez-Gallego, G. and Cuevas, P. (1996) Sleep promoting effects of intravenously administered acidic fibroblast growth factor. Neurological Research, 18, 567-569.
Cuevas, P., Angulo, J. and Giménez-Gallego, G. (2011) Topical treatment of contact dermatitis by pine processionary caterpillar. British Medical Journal (BMJ) Case Reports. http://casereports.bmj.com/content/2011/bcr.06.2011.4351.full.pdf
Hanai, K., Oomura, Y., Kai, Y., Nishikawa, K., Shimizu, N., Morita, H. and Plata-Salamán, C.R. (1989) Central action of acidic fibroblast growth factor in feeding regulation. American Journal of Physiology, 256, R217-R223.